ロード中...
Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of Asthma
Cellular therapy with chimeric antigen receptor (CAR)-redirected cytotoxic T cells has shown impressive efficacy in the treatment of hematologic malignancies. We explored a regulatory T cell (Treg)-based therapy in the treatment of allergic airway inflammation, a model for asthma, which is character...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5600908/ https://ncbi.nlm.nih.gov/pubmed/28955341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.01125 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|